作者：
Michiel,Kroesen [1]
;
Christian,Büll [2]
;
Paul R,Gielen [2]
;
Ingrid C,Brok [2]
;
Inna,Armandari [2]
;
Melissa,Wassink [2]
;
Maaike W G,Looman [2]
;
Louis,Boon [3]
;
Martijn H,den Brok [2]
;
Peter M,Hoogerbrugge [4]
;
Gosse J,Adema [2]
作者单位：
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Pediatric Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
[1]
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands.
[2]
EPIRUS Biopharmaceuticals Netherlands B.V. , Utrecht, The Netherlands.
[3]
Department of Pediatric Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Princes Máxima Center for Pediatric Oncology, De Bilt, The Netherlands.
[4]
DOI
10.1080/2162402X.2016.1164919
PMID
27471639
发布时间
2021-01-12
换一批
换一批
